Biogen (BIIB)

R&D Expense Growth

-13.51%

Quarterly · Period ending:

BIIB logo

BIIB R&D Expense Growth

Latest reported-13.51%
BIIB Quarterly R&D Growth (QoQ) (0.00% → -13.51%)
High-resolution chart · PNG

BIIB r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-13.5079%
12.5074%
37.7976%
-30.251%
-2.9309%
-20.1317%
1.5602%
13.6249%
13.0991%
-19.1197%
-18.7782%
25.1295%
2.6256%
-20.0618%
28.2153%
1.6105%
-3.6372%
-19.4112%
-5.6307%
-32.6209%
97.1583%
-69.0022%
61.4467%
72.5427%
13.8568%
-9.961%
27.9978%
11.4686%
-13.9968%
-7.8319%
14.2323%
-49.2992%
108.4073%
-13.7679%
31.6308%
-51.277%
116.3911%
-20.6968%
0.9263%
11.8157%
8.1866%
-19.2727%
4.1931%
5.9507%
6.5581%
-7.9127%
19.8706%
-6.7294%
-15.4308%
21.8815%
5.8329%
25.2102%
15.166%
-26.8825%
27.8301%
-7.6897%
-7.4174%
5.024%
12.4566%
5.5128%
-2.7207%
540.1557%
-91.2473%
58.0023%
-4.4181%
22.5814%
-6.8978%
-26.9894%
49.011%
-4.5391%
8.9163%
6.5571%
-2.313%
12.6215%
-19.9047%
31.2287%
13.9463%
-63.8775%
151.1456%
30.2793%
11.0308%
-13.3215%
-25.8656%
26.2429%
4.2707%
-8.9562%
12.5586%
-0.8688%
6.8349%
-78.2514%
1,757.7632%
-21.5552%
57.1326%
-65.0113%
-12.7689%
17.0155%
8.3439%
-1.559%
6.1829%
-0.2819%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.